Dr. Paul E Means Jr., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Crossroads Rd, Suite 201, Scottdale, PA 15683 Phone: 724-887-5989 Fax: 724-887-0129 |
Tiffany Pluto, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Crossroads Rd, Suite 201, Scottdale, PA 15683 Phone: 724-887-5989 Fax: 724-887-0129 |
Mark S Williams, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Everson Ave, Scottdale, PA 15683 Phone: 724-887-4550 Fax: 724-887-7485 |
Andrew G Polakovsky, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 Mulberry St, Scottdale, PA 15683 Phone: 724-887-3911 Fax: 724-887-0998 |
Melissa Myers, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Crossroads Rd Ste 201, Scottdale, PA 15683 Phone: 724-887-5989 |
News Archive
In recent years, fine-needle aspiration cytology (FNAC) has become a widely accepted procedure in the diagnosis of bone lesions. Rapid progress in immunocytochemistry and molecular genetics has increased the role of FNAC in the investigation of primary bone lesions.
Today, the American College of Rheumatology, in partnership with the Spondylitis Association of America and the Spondyloarthritis Research and Treatment Network, released the 2019 Update of the Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities for monitoring and stimulation, and of devices for screening new drugs.
Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failure and heart attacks even in adults with normal blood pressure, according to new research published in The Lancet.
Patients whose blood cancers have failed to respond to repeated rounds of chemotherapy may be candidates for a new type of gene therapy that could send their cancers into remission for years.
› Verified 3 days ago